Cheng-Hsu Wang

628 total citations
20 papers, 513 citations indexed

About

Cheng-Hsu Wang is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Cheng-Hsu Wang has authored 20 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 6 papers in Surgery and 6 papers in Otorhinolaryngology. Recurrent topics in Cheng-Hsu Wang's work include Lung Cancer Research Studies (6 papers), Head and Neck Cancer Studies (6 papers) and Cancer Treatment and Pharmacology (3 papers). Cheng-Hsu Wang is often cited by papers focused on Lung Cancer Research Studies (6 papers), Head and Neck Cancer Studies (6 papers) and Cancer Treatment and Pharmacology (3 papers). Cheng-Hsu Wang collaborates with scholars based in Taiwan, United States and Italy. Cheng-Hsu Wang's co-authors include Kun‐Yun Yeh, Chuang‐Chi Liaw, Jen‐Shi Chen, I‐How Chen, Shu‐Hang Ng, Tsai‐Shen Yang, Fu‐Chan Wei, Tseng‐tong Kuo, John Wen‐Cheng Chang and Chih-Hsun Yang and has published in prestigious journals such as Journal of Biological Chemistry, Cancer and Radiotherapy and Oncology.

In The Last Decade

Cheng-Hsu Wang

20 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng-Hsu Wang Taiwan 11 316 157 141 122 118 20 513
Annette M. Lim Australia 14 259 0.8× 165 1.1× 97 0.7× 104 0.9× 194 1.6× 52 565
Charles D. Callery United States 8 266 0.8× 58 0.4× 106 0.8× 148 1.2× 60 0.5× 14 457
S. Alonso Spain 9 448 1.4× 45 0.3× 120 0.9× 114 0.9× 98 0.8× 14 601
Matthew E. Witek United States 14 214 0.7× 134 0.9× 177 1.3× 146 1.2× 111 0.9× 50 578
An‐Cheng Shiau Taiwan 15 147 0.5× 62 0.4× 103 0.7× 162 1.3× 63 0.5× 41 539
Amir Khan Pakistan 13 190 0.6× 38 0.2× 123 0.9× 118 1.0× 115 1.0× 33 530
Stephanie E. McClure United States 9 436 1.4× 425 2.7× 291 2.1× 321 2.6× 90 0.8× 11 727
Anna Cariello Italy 12 196 0.6× 68 0.4× 55 0.4× 156 1.3× 69 0.6× 22 411
Yoshinari Imajo Japan 10 196 0.6× 44 0.3× 128 0.9× 129 1.1× 52 0.4× 40 421
Robert W. Astarita United States 11 179 0.6× 33 0.2× 80 0.6× 112 0.9× 77 0.7× 13 374

Countries citing papers authored by Cheng-Hsu Wang

Since Specialization
Citations

This map shows the geographic impact of Cheng-Hsu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng-Hsu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng-Hsu Wang more than expected).

Fields of papers citing papers by Cheng-Hsu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng-Hsu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng-Hsu Wang. The network helps show where Cheng-Hsu Wang may publish in the future.

Co-authorship network of co-authors of Cheng-Hsu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng-Hsu Wang. A scholar is included among the top collaborators of Cheng-Hsu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng-Hsu Wang. Cheng-Hsu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsieh, Cheng‐En, Yung‐Chih Chou, Chia‐Yen Hung, et al.. (2023). A multicenter retrospective analysis of patients with salivary gland carcinoma treated with postoperative radiotherapy alone or chemoradiotherapy. Radiotherapy and Oncology. 188. 109891–109891. 5 indexed citations
2.
3.
Chou, Wen‐Chi, Keng-Hao Liu, Chang‐Hsien Lu, et al.. (2015). To Operate or Not: Prediction of 3-Month Postoperative Mortality in Geriatric Cancer Patients. Journal of Cancer. 7(1). 14–21. 27 indexed citations
4.
5.
Chang, Pei‐Hung, et al.. (2014). Docetaxel extravasation results in significantly delayed and relapsed skin injury: A case report. Oncology Letters. 7(5). 1497–1498. 9 indexed citations
6.
Wu, Tsung‐Han, Jen‐Seng Huang, Hung‐Ming Wang, Cheng-Hsu Wang, & Kun‐Yun Yeh. (2010). Long-term survivors of adult rhabdomyosarcoma of maxillary sinus following multimodal therapy: case reports and literature reviews.. PubMed. 33(4). 466–71. 9 indexed citations
7.
Chang, John W. C., Jia‐Juan Hsieh, E Ho, et al.. (2009). Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma. Melanoma Research. 19(5). 309–315. 9 indexed citations
8.
Li, Yingying, Wen‐Chi Chou, Chuang‐Chi Liaw, et al.. (2007). Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers. Lung Cancer. 59(2). 180–191. 56 indexed citations
9.
Hong, Ruey‐Long, Ching‐Hung Lin, Tsu-Yi Chao, et al.. (2007). A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline. Cancer Chemotherapy and Pharmacology. 61(5). 847–853. 9 indexed citations
10.
Chang, John Wen‐Cheng, Kun‐Yun Yeh, Cheng-Hsu Wang, et al.. (2004). Malignant melanoma in Taiwan: a prognostic study of 181 cases. Melanoma Research. 14(6). 537–541. 106 indexed citations
11.
Chen, Jen‐Shi, et al.. (2003). Mitomycin C (MMC) with weekly 24-hour infusions of high-dose 5-fluorouracil and leucovorin in patients with advanced gastric cancer.. PubMed. 26(6). 433–9. 3 indexed citations
12.
Wang, Hung‐Ming, Shu‐Hang Ng, Cheng-Hsu Wang, et al.. (2001). Intra-arterial plus i.v. chemotherapy for advanced bulky squamous cell carcinoma of the buccal mucosa. Anti-Cancer Drugs. 12(4). 331–337. 7 indexed citations
13.
Wang, Cheng-Hsu, et al.. (2000). Degradation of DNA Topoisomerase I by a Novel Trypsin-like Serine Protease in Proliferating Human T Lymphocytes. Journal of Biological Chemistry. 275(17). 13109–13117. 11 indexed citations
14.
Lin, Yung‐Chang, Hsien‐Kun Chang, Cheng-Hsu Wang, Jen‐Shi Chen, & Chuang‐Chi Liaw. (2000). Single-agent docetaxel in metastatic breast cancer patients pre-treated with anthracyclines and paclitaxel: partial cross-resistance between paclitaxel and docetaxel. Anti-Cancer Drugs. 11(8). 617–621. 24 indexed citations
15.
Chang, Joseph Tung‐Chieh, Lai‐Chu See, Chun‐Ta Liao, et al.. (2000). Locally recurrent nasopharyngeal carcinoma. Radiotherapy and Oncology. 54(2). 135–142. 122 indexed citations
16.
Wang, Hung‐Ming, et al.. (1999). Impact of Oral Submucous Fibrosis on Chemotherapy-Induced Mucositis for Head and Neck Cancer in a Geographic Area in Which Betel Quid Chewing Is Prevalent. American Journal of Clinical Oncology. 22(5). 485–485. 11 indexed citations
17.
Liaw, Chuang‐Chi, et al.. (1998). Tumor Fever in Patients With Nasopharyngeal Carcinoma. American Journal of Clinical Oncology. 21(4). 422–425. 14 indexed citations
18.
19.
Liaw, Chuang‐Chi, et al.. (1997). Serum Lactate Dehydrogenase Level in Patients with Nasopharyngeal Carcinoma. Acta Oncologica. 36(2). 159–164. 37 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annette M. Lim Breakdown of academic impact, for papers by Charles D. Callery Breakdown of academic impact, for papers by S. Alonso Breakdown of academic impact, for papers by Matthew E. Witek Breakdown of academic impact, for papers by An‐Cheng Shiau Breakdown of academic impact, for papers by Amir Khan Breakdown of academic impact, for papers by Stephanie E. McClure Breakdown of academic impact, for papers by Anna Cariello Breakdown of academic impact, for papers by Yoshinari Imajo Breakdown of academic impact, for papers by Robert W. Astarita
Rankless by CCL
2026